AMRA Medical’s MRI-based Biomarkers Validated in the FNIH’s NIMBLE Study
LINKÖPING, Sweden, October 25, 2023 – Visceral fat, also known as Visceral Adipose Tissue (VAT), is the adipose tissue inside the abdominal…
Read MoreNews
AMRA Used in Tirzepatide Analyses Evaluating the Effect on Muscle Composition via MRI
LINKÖPING, Sweden, October 3, 2023 – Two analyses have shed light on an important factor when evaluating treatments that significantly reduce bodyweight:…
Read More
AMRA Medical´s new CEO is accelerating the company’s position in clinical research
LINKÖPING, Sweden, August 17, 2023 – AMRA Medical, the global leader in body composition analysis, is pleased to announce a set of…
Read More
AMRA Medical´s latest research finds a strong association between personalized body Fat Z-Scores describing skewed fat distribution and specific Cardiometabolic Risk Profiles
LINKÖPING, Sweden, June 28, 2023 – AMRA researchers together with Linköping University used personalized imaging-derived obesity phenotypes, based on a large, population-based…
Read More
Two abstracts accepted for presentation at DDW2023 – Digestive Disease Week®, featuring AMRA Medical’s MRI-based technology and informatics
Interested in how liver transplantation affects your patient’s body composition? Dr. Mohammad S. Siddiqui (Virginia Commonwealth University) presented novel results from a…
Read More
A New Study Finds Strong Association Between Adverse Muscle Composition and All-Cause Mortality in NAFLD
LINKÖPING, Sweden, March 22, 2023 — AMRA researchers together with Linköping University and Virginia Commonwealth University conducted a large, observational study to…
Read More